Summary
Eleven adults have been transplanted for various reasons between July 1979 and July 1982: 2 with aplastic anemia (AA), 1 with paroxysmal nocturnal hemoglobinuria (PNH), 8 with acute leukemia (AL). Four patients suffered from acute lymphocytic leukemia (ALL) and four from acute non-lymphocytic leukemia (ANLL). Two of them were transplanted in relapse, 1 in a partial remission, and 5 in complete remission. All patients were in their late stage of disease. The PNH-patient had an identical twin, 8 patients had an HLA- and MLC compatible sib, 1 an unrelated donor, and 1 was transplanted from his father. Four patients are alive, 2 more than 3 years: 1 with AA and 1 with ALL who was transplanted in relapse. Six patients died of infectious complications (4 of interstitial pneumonia, 1 of a candidasepsis, 1 of acute toxoplasmosis). Patients living more than 3 weeks had a take. Acute graft-versus-host (GvH) disease did not present a major problem. All patients received methotrexate for GvH-prophylaxis, in three instances the marrow was additionally pre-incubated with anti-T-cell globulin.
Similar content being viewed by others
Literatur
Bacigalupo A, Giordano D, Van Lint MT, Vimercati R, Marmont AM (1979) Bolus methylprednisolone in severe aplastic anemia. N Engl J Med 300:501–502
Bortin MM, Kay HEM, Gale RP, Rimm AA (1982) Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet 1:437–439
Fefer A, Freeman H, Storb R, Hill J, Singer J, Edwards A, Thomas F (1976) Paroxysmal nocturnal hemoglobinuria and marrow failure treated by infusion of marrow from an identical twin. Ann Intern Med 84:692–695
Filipovich AH, Ramsay NK, Warkentin PJ, McGlave PhB, Goldstein G, Kersey JH (1982) Pretreatment of donor marrow with monoclonal antibody OKT 3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet 1:1266–1269
Hughes WT, McNabb PC, Makres TD (1974) Efficacy of trimethoprim and sulfamethoxizole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents and Chemother 5:289–293
Jehn U, Wohlrab A, Wilmanns W (1979) Hinweise zur parenteralen Ernährung von Tumor-Patienten. DMW 15:536–540
Jehn U, Wilmanns W (1980) Akute Leukämien des Erwachsenenalters: Therapiemöglichkeiten einschließlich supportiver Maßnahmen. MMW 122:494–498
Jehn U, Ruckdeschel G, Sauer H, Clemm CH, Wilmanns W (1981) Vergleichende Studie zum Wert der selektiven Darmdekontamination (SDD) bei der Behandlung akuter Leukämien. Klin Wochenschr 59:1093–1099
Kersey JH, Kim T, Levitt S, Krivit W, Nesbit ME, Coccia P, Warkentin Ph, O'Leavy M, Ramsay NKC (1980) Combined immunosuppression using cyclophosphamide plus total lymphoid irradiation in preparation for allogeneic marrow transplantation in humans. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, S 333–338
Kolb HJ für die Arbeitsgemeinschaft Knochenmarktransplantation München (1981) Knochenmarktransplantation bei rezidivierter akuter Leukämie. Klin Wochenschr 59:252–266
Netzel B, Rodt H, Haas RJ, Janka G, Thierfelder S (1980) The concept of antileukemic, autologous bone marrow transplantation in acute lymphoblastic leukemia. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunbiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, S. 297–307
Powles RL, Clink HM, Spence D (1980) Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1:327–329
Powles RL, Morgenstern G, Clink HM, Hedely D, Baudini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Janneson B, Lawler S, Kay HEM, McElwain TJ (1980) Bone marrow transplantation in acute myelogenous leukemia. Lancet 1:1047–1050
Powles RL, Clink HM, Bevan D, Leigh M (1982) Mismatched family member bone marrow transplants for acute leukaemia. 3rd Internat. Symposium on Therapy of Acute Leukemias. Abstract S. 368
Riella MC, Scibner BH (1976) Five years' experience with a right atrial catheter for prolonged parenteral nutrition. Surgery 143:205–208
Rodt H, Netzel B, Kolb HJ, Haas RJ, Wilms K, Bender-Götze CH, Niethammer D, Wernet P, Janka G, Link U, Belohradsky B, Wilmanns W, Thierfelder S (1981) Knochenmarktransplantation bei akuter Leukämie; prophylaktische Antiserumbehandlung des Knochemarks zur Unterdrückung einer Transplantat-gegen-Wirt-Reaktion. Blut 43:113–118
Santos GW, Sensenbrenner LL, Burke BJ, Colvin M, Owens AH, Bias WB, Slavin RE (1971) Marrow transplantation in man following cyclophosphamide. Transplant Proc 3:400–404
Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman P (1974) Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43:157–180
Thomas ED (1982) The role of marrow transplantation in the eradication of malignant disease. Cancer 49:1963–1969
Townsend JJ, Wolinsky JS, Baringer JR, Johnson PC (1975) Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol 32:335–343
Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner D, Storb R (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New Engl J Med 300:1068–1073
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED (1981) Antileukemic effect of chronic graft-versus-host disease. New Engl J Med 304:1529–1533
Author information
Authors and Affiliations
Additional information
Arbeitsgemeinschaft Knochenmarktransplantation München e.V. (AG-KMT)
Rights and permissions
About this article
Cite this article
Jehn, U., Sauer, H., Kolb, H.J. et al. Knochenmarktransplantation im Erwachsenenalter bei akuter Leukämie, aplastischer Anämie und paroxysmaler nächtlicher Hämoglobinurie. Klin Wochenschr 61, 321–328 (1983). https://doi.org/10.1007/BF01485022
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01485022